Abstract:Although many researchers of Parkinson's disease (PD) have shifted their focus from the central nervous system (CNS) to the peripheral blood, a significant knowledge gap remains between PD severity and the peripheral immune response. In the current study, we aimed to map the peripheral immunity atlas in peripheral blood mononuclear cells (PBMCs) from PD patients and healthy controls using single-cell RNA sequencing (scRNA-seq). Our study employed scRNA-seq analysis to map the peripheral immunity atlas in PD by profiling PBMCs from PD-Early, PD-Late patients and matched controls. By enlarging the blood sample size, we validated the roles of NK cells in numerous immune-related biological processes. We also detected the infiltration of NK cells into the cerebral motor cortex as the disease progressed, using human brain sections, and elucidated the communication between the periphery and CNS and its implications for PD. As a result, cell subpopulation atlases in PBMCs from PD patients and healthy controls along with differentially expressed genes in NK cells were identified by scRNA-seq analysis, representing 6 major immune cell subsets among which NK cells declined in the progression of PD. We further validated NK cell reduction in increasing samples and found that they participated in numerous immune-related biological processes and infiltration into the cerebral motor cortex as the disease proceeded, evidencingd the close communication between the peripheral immune response and CNS. Strikingly, XCL2 positively correlated with PD severity, with good predictive performance of PD and specific expression in subclusters C2 and C5 of NK cells. All these findings delineated the critical role of peripheral immune response mediated by NK cells in the pathogenesis of PD. NK cell-specific XCL2 could be used as a diagnostic marker for treating PD. The indispensable function of NK cells and NK cell-specific molecular biomarkers highlighted the implication of the peripheral immune response in PD progression. Trial registration: ChiCTR, ChiCTR1900023975. Registered 20 June 2019 - Retrospectively registered, https://www.chictr.org.cn/showproj.html?proj=31035 .

Changes of T lymphocyte subgroups in peripheral blood of Parkionson's disease patients

Changes of T Lymphocyte Subpopulations and Their Roles in Predicting the Risk of Parkinson’s Disease

T Lymphocyte Subgroups and Erythrocyte Immune Function in Parkinson Disease Patients

Abnormal Subpopulations of Peripheral Blood Lymphocytes Are Involved in Parkinson's Disease

Changes of IL-2,IL-6 and IL-10 of Parkionson's Disease Patients

Cytokine and Chemokine Map of Peripheral Specific Immune Cell Subsets in Parkinson's Disease

Clinical Correlation of Peripheral CD4+‑cell Sub‑sets, Their Imbalance and Parkinson's Disease.

Single-cell RNA sequencing reveals peripheral immunological features in Parkinson's Disease

Evidence for Peripheral Immune Activation in Parkinson's Disease.

Th1/Th2 Type Cytokine Gene Expression in the Peripheral Blood of Patients with Parkinson Disease

Differentiation and regulation of CD4+ T cell subsets in Parkinson's disease

Specific immune status in Parkinson’s disease at different ages of onset

Cytokine and chemokine map of peripheral specific immune cell subsets in Parkinson’s disease

Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson’s disease

Imbalance of Circulating Tfh/Tfr Cells in Patients with Parkinson's Disease

Imbalance of circulating Tfh/Tfr cells in patients with Parkinson’s disease

Association Between Peripheral Adaptive Immune Markers and Disease Progression in Parkinson's Disease.

Changes of humoral immune function in patients with Parkinson disease

Imbalance of Circulating Tfh/Tfr Cells in Patients With Parkinson's Disease.

Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients

Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease